Anne-Marie Duliege
2019
In 2019, Anne-Marie Duliege earned a total compensation of $1.6M as Executive Vice President, Chief Medical Officer at Rigel Pharmaceuticals, a 6% decrease compared to previous year.
Compensation breakdown
| Option Awards | $420,682 |
|---|---|
| Salary | $309,783 |
| Other | $869,544 |
| Total | $1,600,010 |
Duliege received $869.5K in other compensation, accounting for 54% of the total pay in 2019.
Duliege also received $420.7K in option awards and $309.8K in salary.
Rankings
In 2019, Anne-Marie Duliege's compensation ranked 7,020th out of 13,971 executives tracked by ExecPay. In other words, Duliege earned more than 49.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,020 out of 13,971 | 50th |
Division Manufacturing | 2,689 out of 5,701 | 53rd |
Major group Chemicals And Allied Products | 988 out of 2,200 | 55th |
Industry group Drugs | 837 out of 1,886 | 56th |
Industry Pharmaceutical Preparations | 615 out of 1,398 | 56th |
Source: SEC filing on April 1, 2020.
Duliege's colleagues
We found six more compensation records of executives who worked with Anne-Marie Duliege at Rigel Pharmaceuticals in 2019.
2019
Raul Rodriguez
Rigel Pharmaceuticals
Chief Executive Officer
2019
Dolly Vance
Rigel Pharmaceuticals
Executive Vice President, Corporate Affairs, General
2019
Dean Schorno
Rigel Pharmaceuticals
Chief Financial Officer
2019
Eldon Mayer
Rigel Pharmaceuticals
Executive Vice President, Chief Commercial Officer
2019
Esteban Masuda
Rigel Pharmaceuticals
Executive Vice President, Research
2019
Wolfgang Dummer
Rigel Pharmaceuticals